These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 17060558)

  • 41. Calculating the number of people with Alzheimer's disease in any country using saturated mutation models of brain cell loss that also predict widespread natural immunity to the disease.
    Kramer I
    Comput Math Methods Med; 2010 Jun; 11(2):119-59. PubMed ID: 20461595
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The etiology of age-related dementia is more complicated than we think.
    McDonald RJ; Craig LA; Hong NS
    Behav Brain Res; 2010 Dec; 214(1):3-11. PubMed ID: 20471430
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A turning point for Alzheimer's disease?
    de la Torre JC
    Biofactors; 2012; 38(2):78-83. PubMed ID: 22422426
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aging, metabolism, and Alzheimer disease: review and hypotheses.
    Finch CE; Cohen DM
    Exp Neurol; 1997 Jan; 143(1):82-102. PubMed ID: 9000448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early-life risk factors for Alzheimer disease.
    Borenstein AR; Copenhaver CI; Mortimer JA
    Alzheimer Dis Assoc Disord; 2006; 20(1):63-72. PubMed ID: 16493239
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Oestrogen: brain ageing, cognition and neuropsychiatric disorder.
    Norbury R; Craig M; Cutter WJ; Whitehead M; Murphy DG
    J Br Menopause Soc; 2004 Sep; 10(3):118-22. PubMed ID: 15494104
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular and cell biological aspects of Alzheimer disease.
    Shastry BS
    J Hum Genet; 2001; 46(11):609-18. PubMed ID: 11721879
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Insulin and Alzheimer's disease: untangling the web.
    Craft S; Cholerton B; Baker LD
    J Alzheimers Dis; 2013; 33 Suppl 1():S263-75. PubMed ID: 22936011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus.
    Fjell AM; McEvoy L; Holland D; Dale AM; Walhovd KB;
    Prog Neurobiol; 2014 Jun; 117():20-40. PubMed ID: 24548606
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The focality of the global Alzheimer brain process: is the selective vulnerability of neurons a specific phenomenon of primary neuronal pathobiology?
    Agius LM
    Med Hypotheses; 2004; 62(5):783-7. PubMed ID: 15082107
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuroinflammatory challenges compromise neuronal function in the aging brain: Postoperative cognitive delirium and Alzheimer's disease.
    Cortese GP; Burger C
    Behav Brain Res; 2017 Mar; 322(Pt B):269-279. PubMed ID: 27544872
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vulnerability and resilience to Alzheimer's disease: early life conditions modulate neuropathology and determine cognitive reserve.
    Lesuis SL; Hoeijmakers L; Korosi A; de Rooij SR; Swaab DF; Kessels HW; Lucassen PJ; Krugers HJ
    Alzheimers Res Ther; 2018 Sep; 10(1):95. PubMed ID: 30227888
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The correlative triad among aging, dopamine, and cognition: current status and future prospects.
    Bäckman L; Nyberg L; Lindenberger U; Li SC; Farde L
    Neurosci Biobehav Rev; 2006; 30(6):791-807. PubMed ID: 16901542
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Molecular abnormality in aging: its contribution to clinical pathology].
    Maruyama N; Ishigami A; Kondo Y
    Rinsho Byori; 2005 Aug; 53(8):728-34. PubMed ID: 16190359
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dissociating Normal Aging from Alzheimer's Disease: A View from Cognitive Neuroscience.
    Toepper M
    J Alzheimers Dis; 2017; 57(2):331-352. PubMed ID: 28269778
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Aging process, cognitive decline and Alzheimer`s disease: can strength training modulate these responses?
    Portugal EM; Vasconcelos PG; Souza R; Lattari E; Monteiro-Junior RS; Machado S; Deslandes AC
    CNS Neurol Disord Drug Targets; 2015; 14(9):1209-13. PubMed ID: 26556087
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Heterogeneity of brain aging: from senile dementia to successful aging].
    Zhang MY
    Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(42):2953-4. PubMed ID: 16324376
    [No Abstract]   [Full Text] [Related]  

  • 58. The aging brain. Changes in the neuronal insulin/insulin receptor signal transduction cascade trigger late-onset sporadic Alzheimer disease (SAD). A mini-review.
    Hoyer S
    J Neural Transm (Vienna); 2002 Jul; 109(7-8):991-1002. PubMed ID: 12111436
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diabetes and Alzheimer's disease crosstalk.
    Baglietto-Vargas D; Shi J; Yaeger DM; Ager R; LaFerla FM
    Neurosci Biobehav Rev; 2016 May; 64():272-87. PubMed ID: 26969101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Biologic differences between early- and late-onset Alzheimer disease.
    Terry RD
    Alzheimer Dis Assoc Disord; 1995; 9 Suppl 1():S26-7. PubMed ID: 7546597
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.